These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 24532681)

  • 21. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
    Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I
    Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
    Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae.
    Takahata S; Senju N; Osaki Y; Yoshida T; Ida T
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3638-45. PubMed ID: 16940068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tracing subsequent dissemination of a cluster of gonococcal infections caused by an ST1407-related clone harbouring mosaic penA alleles in Taiwan.
    Chen CC; Yen MY; Wong WW; Li LH; Huang YL; Chen KW; Li SY
    J Antimicrob Chemother; 2013 Jul; 68(7):1567-71. PubMed ID: 23508619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.
    Liang JY; Cao WL; Li XD; Bi C; Yang RD; Liang YH; Li P; Ye XD; Chen XX; Zhang XB
    BMC Infect Dis; 2016 Apr; 16():152. PubMed ID: 27080231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissemination and genome analysis of high-level ceftriaxone-resistant
    Lin X; Chen W; Xie Q; Yu Y; Liao Y; Feng Z; Qin X; Wu X; Tang S; Zheng H
    Emerg Microbes Infect; 2022 Dec; 11(1):344-350. PubMed ID: 34994305
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel penA mutations identified in Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone isolated between 2000 and 2014 in Japan.
    Seike K; Yasuda M; Hatazaki K; Mizutani K; Yuhara K; Ito Y; Fujimoto Y; Ito S; Tsuchiya T; Yokoi S; Nakano M; Deguchi T
    J Antimicrob Chemother; 2016 Sep; 71(9):2466-70. PubMed ID: 27178830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of decreased susceptibility to ceftriaxone and genotyping of Neisseria gonorrheae isolates in New Delhi, India.
    Mahajan N; Sood S; Das BK; Kapil A; Sreenivas V; Kar HK; Sharma VK
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115423. PubMed ID: 34116342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
    Tanaka M; Nakayama H; Huruya K; Konomi I; Irie S; Kanayama A; Saika T; Kobayashi I
    Int J Antimicrob Agents; 2006 Jan; 27(1):20-6. PubMed ID: 16318912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.
    Gose S; Nguyen D; Lowenberg D; Samuel M; Bauer H; Pandori M
    BMC Infect Dis; 2013 Dec; 13():570. PubMed ID: 24305088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. penA profile of Neisseria gonorrhoeae in Guangdong, China: Novel penA alleles are related to decreased susceptibility to ceftriaxone or cefixime.
    Liao Y; Xie Q; Yin X; Li X; Xie J; Wu X; Tang S; Liu M; Zeng L; Pan Y; Yang J; Feng Z; Qin X; Zheng H
    Int J Antimicrob Agents; 2024 Apr; 63(4):107101. PubMed ID: 38325722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
    Endimiani A; Guilarte YN; Tinguely R; Hirzberger L; Selvini S; Lupo A; Hauser C; Furrer H
    BMC Infect Dis; 2014 Feb; 14():106. PubMed ID: 24568221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoeae isolates from men who have sex with men.
    Calado J; Castro R; Lopes Â; Campos MJ; Rocha M; Pereira F
    Int J Infect Dis; 2019 Feb; 79():116-122. PubMed ID: 30412735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
    Zhao L; Liu A; Li R; Zhao S
    Int J Antimicrob Agents; 2018 Jan; 51(1):52-56. PubMed ID: 28729124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
    Ison CA; Town K; Obi C; Chisholm S; Hughes G; Livermore DM; Lowndes CM;
    Lancet Infect Dis; 2013 Sep; 13(9):762-8. PubMed ID: 23764300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants.
    Demczuk W; Martin I; Sawatzky P; Allen V; Lefebvre B; Hoang L; Naidu P; Minion J; VanCaeseele P; Haldane D; Eyre DW; Mulvey MR
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae.
    Zhao S; Duncan M; Tomberg J; Davies C; Unemo M; Nicholas RA
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3744-51. PubMed ID: 19528266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.
    Peterson SW; Martin I; Demczuk W; Bharat A; Hoang L; Wylie J; Allen V; Lefebvre B; Tyrrell G; Horsman G; Haldane D; Garceau R; Wong T; Mulvey MR
    J Clin Microbiol; 2015 Jul; 53(7):2042-8. PubMed ID: 25878350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.